Osseous Sarcoidosis

  • Eric van StaalduinenEmail author


Skeletal sarcoidosis is thought to occur in approximately 1–13% of patients and generally involves the peripheral skeleton. However, on imaging, some lesions may be indistinguishable from metastatic disease. PET/MR imaging can be used to detect lesions in sarcoidosis as they show intense FDG uptake. Characteristic MRI features and sarcoidosis distribution patterns, combined with simultaneous whole-body FDG PET acquisition, allow for excellent lesion detection, differentiation from malignancy, and assessment of disease activity.


Osseous sarcoidosis Skeletal sarcoidosis Sarcoidosis FDG PET/ MR 

Suggested Reading

  1. Aberg C, Ponzo F, Raphael B, Amorosi E, Moran V, Kramer E. FDG positron emission tomography of bone involvement in sarcoidosis. AJR Am J Roentgenol. 2004;182(4):975–7.CrossRefPubMedGoogle Scholar
  2. Moore SL, Kransdorf MJ, Schweitzer ME, Murphey MD, Babb JS. Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI? AJR Am J Roentgenol. 2012;198(6):1387–93.CrossRefPubMedGoogle Scholar
  3. Simpfendorfer CS, Ilaslan H, Davies AM, James SL, Obuchowski NA, Sundaram M. Does the presence of focal normal marrow fat signal within a tumor on MRI exclude malignancy? An analysis of 184 histologically proven tumors of the pelvic and appendicular skeleton. Skelet Radiol. 2008;37(9):797–804.CrossRefGoogle Scholar
  4. Talmi D, Smith S, Mulligan ME. Central skeletal sarcoidosis mimicking metastatic disease. Skelet Radiol. 2008;37(8):757–61.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2018

Authors and Affiliations

  1. 1.Department of RadiologyStony Brook University HospitalStony BrookUSA

Personalised recommendations